SPC225
Gúselkúmab
Status:
VeittApplication date:
4.5.2018Application published:
15.6.2018Grant published:
15.3.2020
Max expiry date:
27.12.2031Next due date:
31.12.2026Medicine name:
TremfyaMedicine for children:
No
Timeline
Today
4.5.2018Application
15.6.2018Publication
15.3.2020Registration
27.12.2031Expires
Marketing license
IS authorization number:
EU/1/17/1234/001Date:
4.12.2017
Foreign authorization number:
EU/1/17/1234Date:
10.11.2017
Owner
Name:
Janssen Biotech, Inc.Address:
800/850 Ridgeview Drive, Horsham US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1971366